| 0 |
X-RAY ABNORMAL |
1 |
0.0006 |
| 1 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
1 |
0.0005 |
| 2 |
DISLOCATION OF VERTEBRA |
1 |
0.0004 |
| 3 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 4 |
ONYCHOMADESIS |
1 |
0.0002 |
| 5 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 6 |
RHEUMATIC FEVER |
1 |
0.0002 |
| 7 |
FINGER DEFORMITY |
1 |
0.0002 |
| 8 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 9 |
BLEPHAROSPASM |
1 |
0.0002 |
| 10 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 11 |
BREAST CANCER STAGE III |
1 |
0.0002 |
| 12 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 13 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 14 |
MUSCLE INJURY |
1 |
0.0001 |
| 15 |
LIVE BIRTH |
1 |
0.0001 |
| 16 |
NAIL DISORDER |
1 |
0.0001 |
| 17 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 18 |
LIP DRY |
1 |
0.0001 |
| 19 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 20 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 21 |
COELIAC DISEASE |
1 |
0.0001 |
| 22 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 23 |
FOLLICULITIS |
1 |
0.0001 |
| 24 |
BACK INJURY |
1 |
0.0001 |
| 25 |
WOUND INFECTION |
1 |
0.0001 |
| 26 |
BURSITIS |
1 |
0.0001 |
| 27 |
PEMPHIGUS |
1 |
0.0001 |
| 28 |
HAND DEFORMITY |
1 |
0.0001 |
| 29 |
ADVERSE REACTION |
1 |
0.0001 |
| 30 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 31 |
OBESITY |
1 |
0.0001 |
| 32 |
PERICARDITIS |
1 |
0.0001 |
| 33 |
SYNOVITIS |
1 |
0.0001 |
| 34 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 35 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 36 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 37 |
GLOSSODYNIA |
1 |
0.0000 |
| 38 |
FIBROMYALGIA |
1 |
0.0000 |
| 39 |
LIVER INJURY |
1 |
0.0000 |
| 40 |
HEPATITIS |
1 |
0.0000 |
| 41 |
WOUND |
1 |
0.0000 |
| 42 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 43 |
EPILEPSY |
1 |
0.0000 |
| 44 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 45 |
NIGHT SWEATS |
1 |
0.0000 |
| 46 |
IMPAIRED HEALING |
1 |
0.0000 |
| 47 |
GAIT INABILITY |
1 |
0.0000 |
| 48 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 49 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 50 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 51 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 52 |
OSTEOPOROSIS |
1 |
0.0000 |
| 53 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 54 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 55 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 56 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 57 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 58 |
LUNG DISORDER |
1 |
0.0000 |
| 59 |
INFLAMMATION |
1 |
0.0000 |
| 60 |
ARTHROPATHY |
1 |
0.0000 |
| 61 |
NECK PAIN |
1 |
0.0000 |
| 62 |
BLISTER |
1 |
0.0000 |
| 63 |
WHEEZING |
1 |
0.0000 |
| 64 |
STOMATITIS |
1 |
0.0000 |
| 65 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 66 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 67 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 68 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 69 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 70 |
INJURY |
1 |
0.0000 |
| 71 |
SLEEP DISORDER |
1 |
0.0000 |
| 72 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 73 |
MOBILITY DECREASED |
1 |
0.0000 |
| 74 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 75 |
DRY MOUTH |
1 |
0.0000 |
| 76 |
TREATMENT FAILURE |
1 |
0.0000 |
| 77 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 78 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 79 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 80 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 81 |
SWELLING |
1 |
0.0000 |
| 82 |
MIGRAINE |
1 |
0.0000 |
| 83 |
CONTUSION |
1 |
0.0000 |
| 84 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 85 |
DYSPEPSIA |
1 |
0.0000 |
| 86 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 87 |
ASTHMA |
1 |
0.0000 |
| 88 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 89 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 90 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 91 |
JOINT SWELLING |
1 |
0.0000 |
| 92 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 93 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 94 |
INFECTION |
1 |
0.0000 |
| 95 |
HYPOAESTHESIA |
1 |
0.0000 |
| 96 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 97 |
PARAESTHESIA |
1 |
0.0000 |
| 98 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 99 |
URTICARIA |
1 |
0.0000 |
| 100 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 101 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 102 |
MUSCLE SPASMS |
1 |
0.0000 |
| 103 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 104 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 105 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 106 |
ALOPECIA |
1 |
0.0000 |
| 107 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 108 |
HYPERTENSION |
1 |
0.0000 |
| 109 |
WEIGHT INCREASED |
1 |
0.0000 |
| 110 |
DEPRESSION |
1 |
0.0000 |
| 111 |
DECREASED APPETITE |
1 |
0.0000 |
| 112 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 113 |
INSOMNIA |
1 |
0.0000 |
| 114 |
ANXIETY |
1 |
0.0000 |
| 115 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 116 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 117 |
PNEUMONIA |
1 |
0.0000 |
| 118 |
FALL |
1 |
0.0000 |
| 119 |
PYREXIA |
1 |
0.0000 |
| 120 |
ASTHENIA |
1 |
0.0000 |
| 121 |
ARTHRALGIA |
1 |
0.0000 |
| 122 |
RASH |
1 |
0.0000 |
| 123 |
MALAISE |
1 |
0.0000 |
| 124 |
VOMITING |
1 |
0.0000 |
| 125 |
DIZZINESS |
1 |
0.0000 |
| 126 |
DYSPNOEA |
1 |
0.0000 |
| 127 |
PAIN |
1 |
0.0000 |
| 128 |
HEADACHE |
1 |
0.0000 |
| 129 |
DIARRHOEA |
1 |
0.0000 |
| 130 |
FATIGUE |
1 |
0.0000 |
| 131 |
NAUSEA |
1 |
0.0000 |
| 132 |
OFF LABEL USE |
1 |
0.0000 |
| 133 |
DRUG INEFFECTIVE |
1 |
0.0000 |